«BioEq» is going to attend Partnerships in Clinical Trials Europe conference on November 16-17 in Vienna, Austria. The forum is aimed at clinical development acceleration and trial quality improvement by benchmarking and enhancing clinical practices and partnering.
«BioEq» will be represented by Business Development team, who will be keen to meet with pharmaceutical and biotech companies to discuss phase I-III clinical trials in Russia.
To set up a meeting please contact us at bd@«BioEq».ru.
«BioEq» is the first Russian private dedicated clinical research unit conducting phase I-III studies.
«BioEq» is represented by more than 120 experienced employees including industry KOLs in different therapeutic areas.
«BioEq» is a reliable and flexible organization that is able to adjust to its clients’ needs.
«BioEq» has gained profound expertise in First-In-Human Studies, developed a know-how in conducting bioequivalence studies and has a vast experience in phase I-III studies (124 studies approved for «BioEq»).
«BioEq» participated in 3 multicenter research trials submitted to the FDA and in 10 multicenter research trials submitted to EMA.
Looking forward to meeting at the Forum!